ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

SI vs NPCE // 10Y YIELD & FRED MACRO BETA

Shoulder Innovations Inc. (NYSE) VS. Neuropace Inc. (NASDAQ) • 15-METRIC TALLY: SI 4 — NPCE 5
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SI VS. NPCE) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC SI NPCE SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 76.50% 77.20% -0.70 NPCE /gross-margins <GO>
Return on Invested Capital (ROIC) -16.10% -23.00% +6.90 SI /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -8.46% -2.54% -5.92 NPCE /fcf-yield <GO>
Operating Margin -55.60% -16.30% -39.30 NPCE /operating-margins <GO>
Net Profit Margin -60.00% -21.50% -38.50 NPCE /net-margins <GO>
Revenue Growth (YoY) 49.60% 25.10% +24.50 SI /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 8.73 0.20 +8.53 SI /balance-sheet <GO>
Piotroski F-Score Quality 5/9 5/9 0.00 TIE /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 50.8 39.3 +11.54 SI /rsi-technicals <GO>
10Y Yield & FRED Macro Beta ACTIVE — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $425.5M $446.6M -$21.0M NPCE /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR SI REV NPCE REV SI GROSS % NPCE GROSS % SI FCF NPCE FCF
FY 2025 $47.3M $100.0M 76.5% 77.2% -$36.0M -$11.3M
FY 2024 $31.6M $79.9M 77.0% 73.9% -$18.2M -$18.3M
FY 2023 — $65.4M — — — -$19.7M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SI // BETA —
NPCE // BETA —